Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Repligen (RGEN)

Repligen Q2 revenue rises 15% to $182 million; raises 2025 revenue guidance

Positive Impact 4 of 5 earnings Written later

Repligen reported second-quarter 2025 revenue of $182 million, up from $159 million a year earlier, and raised its full-year 2025 total reported revenue guidance to $715 million to $735 million. GAAP earnings per share rose to $0.26 from $0.10, while adjusted earnings per share fell to $0.37 from $0.40, a non-GAAP measure.

Key points

  • Q2 2025 revenue was $182 million, up 15% as reported and 17% organic non-COVID growth.
  • GAAP diluted EPS was $0.26 versus $0.10; adjusted diluted EPS was $0.37 versus $0.40.
  • Full-year 2025 total reported revenue guidance is $715 million to $735 million; GAAP net income guidance is $48 million to $51.5 million.
  • Cash, cash equivalents and short-term investments were $709 million at June 30, 2025, versus $757 million at December 31, 2024.

The filing

CompanyRepligen (RGEN)
Form8-K, current report
Filed with the SECJul 29, 2025, 7:31 AM ET
Accession number0000950170-25-099389

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 29, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.